13/01/2004 - 21:00

Meditech gets foreign backing for cancer test

13/01/2004 - 21:00

Bookmark

Save articles for future reference.

LISTED biotechnology company Meditech has secured funding from Danish-based biotechnology company Novozymes to pursue phase two clinical trials of its anti-cancer treatment, HyCAMP.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options